IS IT SAFE AND COST SAVING TO DEFER THE CD4+ CELL COUNT MONITORING IN STABLE PATIENTS ON ART WITH MORE THAN 350 OR 500 CELLS/µL?

by Benedetto Maurizio Celesia, Dr., Andrea Marino, Dr., Rosa Fontana del Vecchio, Dr., Roberto Bruno, Dr., Filippo Palermo, Professor, Maria Gussio, Dr., Giuseppe Nunnari, Professor, Bruno Cacopardo, Professor
Published 2019-10-01